Browse > Article

Transdermal Drug Delivery System  

Jin, Hwa Eun (Yonsei Center for Nano Technology)
Kim, Jung Hyun (Yonsei University, Chemical Engineeering)
Paik, Il Young (Yonsei University, Physical Education)
Publication Information
Applied Chemistry for Engineering / v.16, no.1, 2005 , pp. 15-20 More about this Journal
Abstract
Many scientists have been interested in drug delivery system (DDS) which improves medical treatment for curing a disease. Transdermal drug delivery (TDD) that is one of the DDS offers several advantages over the traditional methods. For this reason, the study of TDD has been investigated in various field. In this paper, principle of transdermal delivery and penetration enhancers into the skin including in vitro and in vivo data have been studied.
Keywords
transdermal drug delivery (TDD); permeation; penetration enhancer; stratum corneum;
Citations & Related Records
연도 인용수 순위
  • Reference
1 J. A. Bouwstra and P. L. Honeywell-Nguyen, Advanced Drug Delivery Review, 54, S41 (2002)   DOI   ScienceOn
2 G. L. Wilkes, I. A. Brown, and R. H. Widnauer, Critical Review of Bioengineering, 1, 453 (1973)
3 M. A. Lampe, A. L. Burligame, J. Whitney, M. L. Williams, B. E. Brown, E. Roitman, and P. M. Elias, J. Lipid Research, 24, 120 (1983)
4 P. M. Elias, International J. Dermatology, 20, 1 (1981)   DOI
5 S. Grayson and P. M. Elias, J. Investigative Dermatology, 78, 128 (1982)   DOI   ScienceOn
6 M. L. Williams and P. M. Elias, Critical Reviews in Therapeutic Drug Carrier Systems, 3, 95 (1987)
7 P. W. Wertz and D. T. Downing, Transdermal Drug Delivery: Developmental Issues and Research Initiatives, eds. J. Hadgraft, and R. H. Guy, 1, Marcel Dekker, New York, Basel, Hong Kong (1989)
8 E. French, C. Potton, and K. Walters, Pharmaceutical Skin Penetration Enhancement, eds. K. Walters, and J. Hadgraft, 113, Marcel Dekker, New York (1993)
9 U. T. Lashmar, J. Hdgraft, and N. Thomas, J. Pharmacy and Pharmacology, 41, 118 (1989)   DOI
10 D. Southwell and B. W. Barry, J. Investigative Dermatology, 80, 507 (1983)   DOI   ScienceOn
11 B. Berner, G. C. Mazzenga, J. H. Otte, R. J. Steffens, R. H. Juang, and C. D. Ebert, J. Pharmacological Sciences, 78, 402 (1989)   DOI
12 R. L. Bronaugh and H. I. Maibach, Percutaneous Penetration, Marcel Dekker, London (1985b)
13 M. E. Roberts and K. R. Mueller, Pharmaceutical Research, 7, 673 (1990)   DOI
14 K. Harada, T. Murakami, E. Kawasaki, Y. Hagashi, S. Yamamoto, and N. Yata, J. Pharmacy and Pharmacology, 45, 414 (1993)   DOI   ScienceOn
15 P. W. Wertz, K. C. Madison, and Downing, D. T. Investigative Dermatology, 92, 109 (1989)   DOI   ScienceOn
16 R. L. Potts, Physical Characterization of the Stratum Corneum: the Relationship of Mechanical and Barrier Properties to Lipid and Protein Structure, Transdermal Drug Delivery; Developmental Issues and Research Initiatives, eds. J. Hadgraft, and R. H. Guy, Ch. 2, Marcel Dekker, New York (1989)
17 P. M. Elias and D. S. Friend, Journal of Cell Biology, 65, 180 (1975)   DOI   ScienceOn
18 S. H. White, D. Mirejovsky, and G. I. King, Biochemistry, 27, 3725 (1988)   DOI   ScienceOn
19 A. C. Williams and B. W. Barry, Critical Reviews in Therapeutic Drug Carrier Systems, 9, 305 (1992)
20 E. J. Wood and P. T. Bladon, The Human Skin: Studies in Biology Series, 164, Edward Arnold, London (1985)
21 M. Goodman and B. W. Barry, International J. Pharmacology, 57, 29 (1989)   DOI   ScienceOn
22 M. Suhonen, J. Bouwstra, and A. Urtti, J. Controlled Release, 59, 149 (1999)   DOI   ScienceOn
23 R. Aboofazeli, H. Zia, and T. E. Needham, Drug Delivery, 9, 239 (2002)   DOI
24 W. G. Reinfenrath, E. M. Chellquist, E. A. Shipwash, W. W. Jederberg, and G. G. Krueger, British J. Dermatology, 111, 123 (1984)
25 R. A. Tupker, J. Pinnagoda, and J. P. Nater, Acta DermatoVenereologica, 70, 1 (1900)
26 K. Knutson, R. O. Potts, D. B. Guzek, G. M. Golden, J. E. McKie, W. J. Lambert, and W. I. Higuchi, Macro- and Molecular Physical-Chemical Considerations in Understanding Drug Transport in the Stratum Corneum, In Advances in Drug Delivery Systems, eds. J. M. Anderson, and S. W. Kimeds, 1, 67, Elsevier, Amsterdam (1986)
27 M. K. Robinson and M. A. Perkins, American J. Contact Dermatitis, 13, 19 (2002)   DOI   ScienceOn
28 B. W. Barry, Dermatological Formulations: Percutaneous Absorption. Drugs and the Pharmaceutical Sciences, 18, Marcel Dekker, New York (1983)
29 M. J. Bartek, J. A. LaBudde, and H. I. Maibach, J. Investigative Dermatology, 58, 114 (1972)   DOI   ScienceOn
30 S. Santoyo and P. Ygartua, European J. Pharmaceutical Biopharmacetics, 50, 245 (2000)   DOI   ScienceOn
31 T. Pongjanyakul, S. Prakongpan, S. Panomsuk, S. Puttipipathkhachorn, and A. Priprem, J. Pharmacy and Pharmacology, 54, 1345 (2002)   DOI   ScienceOn
32 S. Mitragotri, D. Blankschtein, and R. Langer, Science, 269, 850 (1995)   DOI   ScienceOn
33 R. H. Guy, Pharmacological Research, 13, 1765 (1996)   DOI
34 A. C. Williams and B. W. Barry, Advanced Drug Delivery Reviews, 56, 603 (2004)   DOI   ScienceOn
35 H. I. Maibach, Animal Models in Dermatology, Churchill- Livingstone, Edinburgh (1975)
36 D. R. Friend, Journal of Controlled Release, 18, 235 (1992)   DOI   ScienceOn
37 H. C. Ansel, N. G. Popovich, and L. V. Allen, Pharmaceutical Dosage Forms and Drug Delivery Systems, 357, Williams and Wilkins, Malvern (1995)
38 K. Moser, K. Kriwet, A. Naik, Y. N. Kalia, and R. H. Guy, European J. Pharmaceutics and Biopharmaceutics and Biopharmaceutics, 52, 103 (2001)   DOI   ScienceOn
39 T. J. Franz, J. Investigative Dermatology, 64, 190 (1975)   DOI   ScienceOn
40 G. P. Moss, J. C. Dearden, H. Patel, and M. T. Cronin, Toxicology in vitro, 16, 299 (2002)   DOI   ScienceOn
41 P. Karande, A. Jain, and S. Mitragotri, Nature Biotechnology, 22, 192 (2004)   DOI   ScienceOn
42 N. Kanikkannan, K. Kanimalla, S. S. Lamba, and M. Singh, Current Medical Chemistry, 7, 593 (2000)   DOI   ScienceOn
43 R. L. Bronaugh, R. F. Stewart, E. R. Congdon, and A. L. Giles, Applied Pharmacology, 62, 481 (1982)   DOI   ScienceOn
44 R. M. Marks, S. P. Barton, and C. Edwards, The physical Nature of the Skin, MTP Press Ltd., Lancaster (1988)
45 B. C. Finnin and T. M. Morgan, J. Pharmaceutical Science, 88, 955 (1999)   DOI
46 S. Mitragotri, Pharmacological Research, 18, 1022 (2001)
47 E. S. Park, S. J. Chang, Y. S. Rhee, and S. C. Chi, Drug Development and Industrial Pharmacy, 27, 975 (2001)   DOI   ScienceOn
48 F. N. Marzulli and H. I. Maibach, Relevance of Animal Models: the Hexachlorophene Story, ed. H. I. Maibach, Animal Models in Dermatology, Churchill-Livingstone, Edinburgh (1975)
49 R. H. Guy, Y. N. Kalia, M. B. Delgado-Charro, V. Merino, A. Lopez, and D. Marro, Journal of Controlled Release, 64, 129 (2000)   DOI   ScienceOn
50 J. D. Bos and M. M. Meinardi, Experimental Dermatology, 9, 165 (2000)   DOI   ScienceOn
51 B. W. Barry, The LPP Theory of Skin Penetration, in In Vitro Percutaneous Absorption: Principles, Fundamentals and Applications, eds. R. L. Bronaugh, and H. I. Maibach, 165, CRC Pres. Boca Raton (1991)
52 A. M. Kligman, JAMA, 193, 796 (1965)   DOI   ScienceOn
53 J. H. W. Mali, Current Problems in Dermatology, 7, Karger, Basel ( 1978)
54 T. Kurihara-Bergstrom, K. Knutson, L. J. De Noble, and C. Y. Goates, Pharmacological Research, 7, 762 (1990)   DOI
55 R. L. Bronaugh and H. I. Maibch, J. Investigative Dermatology, 84, 180 (1985a)   DOI   ScienceOn